View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Optometry News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 02, 2024
7 min watch
Save

VIDEO: Supplemental treatment not needed in two-thirds of eyes that received EYP-1901

VIDEO: Supplemental treatment not needed in two-thirds of eyes that received EYP-1901

In this Healio Video Perspective from the ASRS meeting, Ashkan M. Abbey, MD, of Texas Retina Associates discusses data from the DAVIO 2 trial investigating EYP-1901 for the treatment of wet age-related macular degeneration.

SPONSORED CONTENT
August 02, 2024
5 min read
Save

The AI 'landscape is vast' in health care, but which products are available?

Health care providers know of the broad potential AI offers for reducing burnout, but which products are actually available for use can be difficult to ascertain, especially considering electronic health record system compatibility.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
August 02, 2024
8 min watch
Save

Jullia A. Rosdahl, MD, PhD, on protecting your colleagues: Recognize the signs of burnout

Jullia A. Rosdahl, MD, PhD, on protecting your colleagues: Recognize the signs of burnout

Hi everyone. Welcome to another episode of season two of "Our View," our Healio vlog focusing on physician wellness. And we're joined today by Dr. Rosdahl from Duke. Dr. Rosdahl, can you tell us about your roles at Duke?

SPONSORED CONTENT
August 02, 2024
3 min read
Save

Q&A: Retiring Optometry Giving Sight exec calls rate of unnecessary blindness ‘staggering’

Q&A: Retiring Optometry Giving Sight exec calls rate of unnecessary blindness ‘staggering’

After serving as executive director at Optometry Giving Sight for the past 2 years, Lois Schoenbrun, FAAO, will retire in December 2024, the nonprofit organization announced in a press release.

SPONSORED CONTENT
August 02, 2024
3 min read
Save

BLOG: Post-refractive ectasia: Outcomes and expectations

BLOG: Post-refractive ectasia: Outcomes and expectations

Post-refractive ectasia is very rare. The incidence is only about 0.1% per 100,000 eyes undergoing LASIK and less than that in eyes undergoing PRK or SMILE.

SPONSORED CONTENT
August 02, 2024
3 min read
Save

GLP-1s not tied to higher risk for form of optic neuropathy that may cause blindness

GLP-1s not tied to higher risk for form of optic neuropathy that may cause blindness

Adults using a GLP-1 receptor agonist do not have increased risk for nonarteritic anterior ischemic optic neuropathy, according to data from a retrospective analysis published in Journal of Diabetes Science and Technology.

SPONSORED CONTENT
August 01, 2024
2 min read
Save

Nearly 40% of children with glaucoma do not undergo yearly visual field testing

Nearly 40% of children with glaucoma do not undergo yearly visual field testing

While most children with glaucoma have at least one visual field test per year, Black and multiracial children were among those with significantly lower testing frequency, according to a single-center study published in Journal of Glaucoma.

SPONSORED CONTENT
August 01, 2024
1 min read
Save

Establishing vitrectomy parameters may help determine case complexity

Establishing vitrectomy parameters may help determine case complexity

Defining intraoperative parameters for vitrectomy may help shed light on the complexity of a case, according to a study presented at the American Society of Retina Specialists meeting.

SPONSORED CONTENT
August 01, 2024
3 min read
Save

BLOG: Start planning now for World KC Day

BLOG: Start planning now for World KC Day

World KC Day, a global event sponsored by the National Keratoconus Foundation to promote awareness of keratoconus, is celebrated annually on Nov. 10.

SPONSORED CONTENT
August 01, 2024
1 min read
Save

European Commission approves Vabysmo for retinal vein occlusion

European Commission approves Vabysmo for retinal vein occlusion

The European Commission approved Vabysmo for the treatment of visual impairment due to macular edema secondary to retinal vein occlusion, according to a press release from Roche.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails